Company Filing History:
Years Active: 2021
Title: Hsiu-Fen Lee: Innovator in Genetic Research
Introduction
Hsiu-Fen Lee is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of genetic research, particularly in the area of gene therapy. His work focuses on developing innovative solutions to address genetic disorders.
Latest Patents
Hsiu-Fen Lee holds a patent for an "Antisense oligonucleotide for splicing adjustment of mutant dopa decarboxylase gene and using method thereof." This invention discloses an antisense oligonucleotide that is complementary to SEQ ID NO: 1. It can modulate the alternative splicing site of the mutant dopa decarboxylase gene. This innovation is particularly beneficial for researching and developing drugs to treat AADC deficiency symptoms. The patent also outlines a method for using the antisense oligonucleotide in vitro.
Career Highlights
Hsiu-Fen Lee is affiliated with Taichung Veterans General Hospital, where he conducts his research. His work has garnered attention for its potential impact on treating genetic disorders. He has demonstrated a commitment to advancing medical science through innovative research.
Collaborations
Hsiu-Fen Lee collaborates with notable colleagues, including Chi-Ren Tsai and Ching-Shiang Chi. These partnerships enhance the research efforts and contribute to the development of effective treatments for genetic conditions.
Conclusion
Hsiu-Fen Lee's contributions to genetic research exemplify the importance of innovation in medicine. His patent and ongoing work hold promise for improving the lives of individuals affected by genetic disorders.